Berlin's pharmaceutical companies generate around 13 percent of the overall turnover in pharmaceuticals in Germany, making Berlin the capital of the pharmaceutical industry.
»Berlin has an excellent clinical and research landscape and is an attractive location for many reasons. We want to be successful as a pharmaceutical company, but we can only achieve this with committed and well-qualified staff, with the right partners, a good environment and the appropriate infrastructure. Berlin offers all of this«Dieter Weinand, Member of the Bayer AG Board of Management and Head of the Pharmaceuticals Division, headquartered in Berlin
Berlin has become one of the major and most attractive centers of the medical and health services industries in Germany. The colossal growth of the pharmaceuticals sector in the German capital makes this industry the driving force behind the upswing of the Berlin economy.
The following factors all work to benefit the sector:
- An excellent environment for science and research
- Berlin's clinical research environment
- The proximity to decision makers in the healthcare system
- The high availability of well-trained technical experts
In increasing numbers, global players and medium-sized companies alike are moving to Berlin or relocating their headquarters to the German capital in order to put these advantages to the best possible use.
The exceptional opportunities for cooperating with renowned universities, research institutions and biotechnology companies are an excellent basis on which to pursue innovative projects for the future.
Currently, about 30 pharmaceutical companies have their offices in the capital region, employing around 10,000 people.